The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
Tokyo, Japan and Cambridge, UK, 23 October 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – is pleased to announce that it has won ...
Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...
An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...
C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced the appointment of Paige Mahaney, Ph ...
GlobalData on MSN9d
Boehringer partners WHO Foundation to advance healthcare accessBoehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...
An investigational oral fatty acid synthase (FASN) inhibitor was associated with significant improvements in metabolic ...
As Hurricane Milton made landfall in Florida Wednesday night, drugmakers, regulators, hospitals and health agencies alike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback